A push to track patients switching between originator biologics and their biosimilars through a national database has hit a brick wall, after the federal government dismissed the need for it. The Australian Rheumatology Association says a national database of prescribing and dispensing data for inflammatory arthritis patients is needed to monitor the safety and efficacy ...
Hopes dashed for bDMARD register
By Tessa Hoffman
18 Jan 2018